Against this background, we present a secondary analysis of double-blind, cluster-randomized trial data [22] aimed at determining the effect of ABO blood groups, haemoglobin and G6PD genotypes against the risk of malaria and anaemia among Ghanaian infants and young children receiving iron-containing MNP in high malaria burden areas. The gene discussed is G6PD; the disease is malaria.